Contact this trialFirst, we need to learn more about you.
Virus Therapy
Q-Griffithsin for COVID-19
Recruiting0 awardsPhase 1
Pittsburgh, Pennsylvania
This trial is testing a new drug to see if it is safe for humans. The drug will be given to adults through a nasal spray, and they will be monitored for side effects. If the drug is safe, participants will use it for 13 more days. The trial will last for 6-8 weeks total.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.